Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Daiichi Sankyo
Fuji
Dow
McKesson
Moodys
AstraZeneca
Chubb
Express Scripts

Generated: June 20, 2018

DrugPatentWatch Database Preview

Bacampicillin hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for bacampicillin hydrochloride and what is the scope of bacampicillin hydrochloride freedom to operate?

Bacampicillin hydrochloride
is the generic ingredient in one branded drug marketed by Pfizer and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for bacampicillin hydrochloride.
Summary for bacampicillin hydrochloride
Synonyms for bacampicillin hydrochloride
(2S,5R,6R)-6-((R)-(2-Amino-2-phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid ester with ethyl 1-hydroxyethyl carbonate, monohydrochloride
(2S,5R,6R)-6-[[(2R)-2-amino-1-oxo-2-phenylethyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 1-ethoxycarbonyloxyethyl ester hydrochloride
1-((Ethoxycarbonyl)oxy)ethyl (2S-(2alpha,5alpha,6beta(S*)))-6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate monohydrochloride
1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate hydrochloride
1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-azanyl-2-phenyl-ethanoyl]amino]-3,3-dimethyl-7-oxidanylidene-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate hydrochloride
37661-08-8
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, 1-((ethoxycarbonyl)oxy)ethyl ester, hydrochloride
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, 1-((ethoxycarbonyl)oxy)ethyl ester, monohydrochloride, (2S-(2alpha,5alpha,6beta(S*)))-
50972-17-3 (Parent)
A823813
AC1L9B3G
AK129722
AKOS016014246
Ambacamp
Ambaxin
API0000413
AX8020538
Bacacil
Bacampicillin (hydrochloride)
bacampicillin HCl
Bacampicillin hydrochloride (JP17/USP)
Bacampicillin hydrochloride [USAN:USP:JAN]
Bacampicillin hydrochoride
BACAMPICILLINHYDROCHLORIDE
BAPC
C08123
C21H27N3O7S.HCl
CAS-37661-08-8
CCG-220416
CHEBI:2969
CHEMBL1200965
CS-4754
D00927
DSSTox_CID_25466
DSSTox_GSID_45466
DSSTox_RID_80897
DTXSID0045466
EINECS 253-580-4
HMS1569C14
HY-B1149A
IWVTXAGTHUECPN-ANBBSHPLSA-N
MLS002153801
MolPort-019-996-595
NCGC00016837-01
NCGC00179582-03
Penglobe
Prestwick_776
SCHEMBL124593
SMR001233177
Spectrobid
Spectrobid (TN)
SureCN721373
Tox21_110640
Tox21_110640_1
Velbacil

US Patents and Regulatory Information for bacampicillin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer SPECTROBID bacampicillin hydrochloride TABLET;ORAL 050520-002 Sep 12, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer SPECTROBID bacampicillin hydrochloride TABLET;ORAL 050520-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer SPECTROBID bacampicillin hydrochloride FOR SUSPENSION;ORAL 050556-001 Mar 23, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Harvard Business School
QuintilesIMS
Citi
McKinsey
Cipla
Teva
Dow
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.